Digest Network Come funziona
Network
/
Società
Mi
Non verificato

MindWalk Holdings Corp.

Di cosa scriviamo

BiotecnologiaHIV, AIDS e malattie autoimmuniSaluteScienzaTecnica

36 comunicati stampa

Guarda tutti i comunicati
22/10/2026
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
Farmaceutica
Biotecnologia
Mercato del lavoro
MindWalk Holdings Corp. Announces Leadership Update
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
21/10/2026
Multimedialità
Scienza
Tecnica
HIV, AIDS e malattie autoimmuni
Tecnologie Varie
Biotecnologia
Farmaceutica
Salute
Industria
MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
14/10/2026
Tecnica
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Salute
Farmaceutica
Mercato del lavoro
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
06/10/2026
Industria
Tecnica
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Salute
Farmaceutica
MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
01/10/2026
Mercato del lavoro
Software
Scienza
Farmaceutica
Information Technology
Tecnica
HIV, AIDS e malattie autoimmuni
Biotecnologia
Salute
MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
21/09/2026
Industria
Biotecnologia
Tecnica
Salute
Farmaceutica
Scienza
HIV, AIDS e malattie autoimmuni
Software
MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
14/09/2026
Biotecnologia
Tecnica
Salute
Farmaceutica
Tecnologie Varie
Scienza
HIV, AIDS e malattie autoimmuni
Software
Web e Social Network
Telefonia e Varie
Mercato azionario
MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
14/09/2026
Biotecnologia
Tecnica
Sanità
Salute
Scienza
Tecnologie Varie
HIV, AIDS e malattie autoimmuni
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
10/09/2026
Eventi
Scienza
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
08/09/2026
Mercato azionario
Finanza
Web e Social Network
Telefonia e Varie
Scienza
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0